• Antipsychotic use in pregnancy and risk of attention/ deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study 

      Halfdanarson, Oskar; Cohen, Jacqueline Mallory; Karlstad, Øystein; Cesta, Carolyn E.; Bjørk, Marte-Helene; Håberg, Siri Eldevik; Einarsdottir, Kristjana; Furu, Kari; Gissler, Mika; Hjellvik, Vidar; Kieler, Helle; Leinonen, Maarit; Nørgaard, Mette; Essen, Buket Öztürk; Ulrichsen, Sinna Pilgaard; Reutfors, Johan; Zoega, Helga (Journal article; Peer reviewed, 2021)
      Background Antipsychotics are increasingly used among women of childbearing age and during pregnancy. Objective To determine whether children exposed to antipsychotics in utero are at increased risk of attention-d ...
    • Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study 

      Graner, Sophie; Svensson, Tobias; Beau, Anna-Belle; Damase-Michel, Christine; Engeland, Anders; Furu, Kari; Hviid, Anders; Håberg, Siri Eldevik; Mølgaard-Nielsen, Ditte; Pasternak, Björn; Kieler, Helle (Peer reviewed; Journal article, 2017)
      Objective: To evaluate the possible effects of exposure to neuraminidase inhibitors during embryo-fetal life with respect to adverse neonatal outcomes and congenital malformations. Design: Population based multinational ...
    • Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries 

      Dudukina, Elena; Szépligeti, Szimonetta Komjáthiné; Karlsson, Pär; Asomaning, Kofi; Daltveit, Anne Kjersti Nesje; Hakkarainen, Katja; Hoti, Fabian; Kieler, Helle; Lunde, Astrid; Odsbu, Ingvild; Rantanen, Matti; Reutfors, Johan; Saarelainen, Laura; Ehrenstein, Vera; Toft, Gunnar (Journal article; Peer reviewed, 2023)
      Introduction: Pregabalin is an antiepileptic drug frequently prescribed to pregnant women. Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal exposure to pregabalin are uncertain. Objective: ...
    • Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design 

      Furu, Kari; Kieler, Helle; Haglund, Bengt; Engeland, Anders; Selmer, Randi; Stephansson, Olof; Valdimarsdottir, Unnur Anna; Zoega, Helga; Artama, Miia; Gissler, Mika; Malm, Heli; Nørgaard, Mette (Peer reviewed; Journal article, 2015)
      Objective To assess whether use of specific selective serotonin reuptake inhibitors (SSRIs) or venlafaxine in early pregnancy is associated with an increased risk of birth defects, with emphasis on cardiovascular birth ...
    • Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries 

      Kieler, Helle; Artama, Miia; Engeland, Anders; Ericsson, Örjan; Furu, Kari; Gissler, Mika; Nielsen, Rikke Beck; Nørgaard, Mette; Stephansson, Olof; Valdimarsdottir, Unnur; Zoega, Helga; Haglund, Bengt (Journal article, 2012-01-12)
      Objective: To assess whether maternal use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of persistent pulmonary hypertension in the newborn, and whether such an effect might differ between specific ...
    • Setting research priorities to improve global newborn health and prevent stillbirths by 2025 

      Yoshida, Sachiyo; Martines, Jose Carlos; Lawn, Joy E.; Wall, Stephen; Souza, João Paulo; Rudan, Igor; Cousens, Simon; Aaby, Peter; Adam, Ishag; Adhikari, Ramesh Kant; Ambalavanan, Namasivayam; Arifeen, Shams EI; Aryal, Dhana Raj; Asiruddin, Sk K.; Baqui, Abdullah; Barros, Aluisio J.D.; Benn, Christine S.; Bhandari, Vineet; Bhatnagar, Shinjini; Bhattacharya, Sohinee; Bhutta, Zulfiqar A.; Black, Robert E.; Blencowe, Hannah; Bose, Carl; Brown, Justin; Bührer, Christoph; Carlo, Wally; Cecatti, Jose Guilherme; Cheung, Po-Yin; Clark, Robert; Colbourn, Tim; Conde-Agudelo, Agustin; Corbett, Erica; Czeizel, Andrew E.; Das, Abhik; Day, Louise Tina; Deal, Carolyn; Deorari, Ashok; Dílmen, Uǧur; English, Mike; Esamai, Fabian; Fall, Caroline; Ferriero, Donna M.; Gisore, Peter; Hazir, Tabish; Higgins, Rosemary D.; Homer, Caroline S.E.; Hoque, Dewan Emdadul; Irgens, Lorentz M.; Islam, Mohammad Tajul; de Graft-Johnson, Joseph; Joshua, Martias Alice; Keenan, William; Khatoon, Soofia; Kieler, Helle; Kramer, Michael S.; Lackritz, Eve M.; Lavender, Tina; Lawintono, Laurensia; Luhanga, Richard; Marsh, David; McMillan, Douglas; McNamara, Patrick J.; Mol, Ben Willem J.; Molyneux, Elizabeth; Mukasa, Gelasius K.; Mutabazi, Miriam; Nacul, Luis Carlos; Nakakeeto, Margaret; Narayanan, Indira; Olusanya, Bolajoko; Osrin, David; Paul, Vinod; Poets, Christian; Reddy, Uma M; Santosham, Mathuram; Sayed, Rubayet; Schlabritz-Loutsevitch, Natalia E.; Singhal, Nalini; Smith, Mary Alice; Smith, Peter G.; Soofi, Sajid; Spong, Catherine Y.; Sultana, Shahin; Tshefu, Antoinette; van Bel, Frank; Gray, Lauren Vestewig; Waiswa, Peter; Wang, Wei; Williams, Sarah L.A.; Wright, Linda; Zaidi, Anita; Zhang, Yanfeng; Zhong, Nanbert; Zuniga, Isabel; Bahl, Rajiv (Peer reviewed; Journal article, 2016-06)
      Background: In 2013, an estimated 2.8 million newborns died and 2.7 million were stillborn. A much greater number suffer from long term impairment associated with preterm birth, intrauterine growth restriction, congenital ...
    • Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia 

      Cesta, Carolyn E.; Segovia Chacón, Silvia; Engeland, Anders; Broe, Anne; Damkier, Per; Furu, Kari; Kieler, Helle; Karlsson, Pär (Journal article; Peer reviewed, 2021)
      Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for ...